Concepedia

David A. Rider

DA

20

Publications

1K

Citations

16

H-Index

2003

Active since

Affiliations

University of Birmingham(Current)

National University of Singapore

Institute of Molecular and Cell Biology

Agency for Science, Technology and Research

Silence Therapeutics (United Kingdom)

David A. Rider is an author at University of Birmingham specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

2003–2024

20

Publications

20

Autocrine Fibroblast Growth Factor 2 Increases the Multipotentiality of Human Adipose-Derived Mesenchymal Stem Cells

David A. Rider, Christian Dombrowski, Amber A. Sawyer et al. · Stem Cells · 2008 · 152 citations · Full text

FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis

Jack Leslie, Ben Millar, Alicia del Carpio Pons et al. · JCI Insight · 2020 · 95 citations · Full text

Altered T-Cell Function in Schizophrenia: A Cellular Model to Investigate Molecular Disease Mechanisms

Rachel Craddock, Helen Lockstone, David A. Rider et al. · PLoS ONE · 2007 · 94 citations · Full text

, , +19

Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)

Steven E. Nissen, Qiuqing Wang, Stephen J. Nicholls et al. · JAMA · 2024 · 80 citations · Full text

Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cells

Ling Ling, Emily T. Camilleri, Torben Helledie et al. · Gene · 2015 · 73 citations · Full text

, , +10

Rows per page

1–5 of 20